|
EEF1E1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.055600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.131600E-01 |
| Normal-vs-Stage2 |
1.991000E-01 |
| Normal-vs-Stage3 |
1.394840E-01 |
| Normal-vs-Stage4 |
9.315300E-03 |
| Stage1-vs-Stage2 |
5.248600E-01 |
| Stage1-vs-Stage3 |
6.143600E-01 |
| Stage1-vs-Stage4 |
9.607600E-02 |
| Stage2-vs-Stage3 |
7.537400E-01 |
| Stage2-vs-Stage4 |
5.573200E-01 |
| Stage3-vs-Stage4 |
2.280400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.784000E-02 |
| Normal-vs-AfricanAmerican |
3.671200E-01 |
| Normal-vs-Asian |
5.537400E-01 |
| Caucasian-vs-AfricanAmerican |
9.013000E-01 |
| Caucasian-vs-Asian |
5.679400E-01 |
| AfricanAmerican-vs-Asian |
7.757000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.138270E-02 |
| Normal-vs-Female |
2.219200E-01 |
| Male-vs-Female |
5.968500E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.738000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.749700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.680400E-02 |
| Normal-vs-Age(81-100Yrs) |
2.488400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.358800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.903770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.453000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.723200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.174200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.212000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.891580E-01 |
| Classical-VS-Follicular |
5.361600E-02 |
| Classical-VS-Other |
3.591800E-01 |
| Classical-VS-Normal |
3.666200E-01 |
| Tall-VS-Follicular |
4.771600E-02 |
| Tall-VS-Other |
2.164400E-01 |
| Tall-VS-Normal |
6.137600E-01 |
| Follicular-VS-Other |
9.752000E-01 |
| Follicular-VS-Normal |
1.956020E-02 |
| Other-VS-Normal |
3.858800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.086100E-02 |
| Normal-vs-N1 |
5.281800E-02 |
| N0-vs-N1 |
4.933400E-01 |
|
|
